Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2025-12-26 @ 3:43 AM
Study NCT ID:
NCT00323518
Status:
COMPLETED
Last Update Posted:
2016-04-13
First Post:
2006-05-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
Sponsor:
CuraGen Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CG53135-CLN-12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None